(Q42227308)

English

Preoperative hepatitis B virus DNA level is a risk factor for postoperative liver failure in patients who underwent partial hepatectomy for hepatitis B-related hepatocellular carcinoma

scientific article published on September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

Preoperative hepatitis B virus DNA level is a risk factor for postoperative liver failure in patients who underwent partial hepatectomy for hepatitis B-related hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

19 October 2017

0 references

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Gang Huang

1

1 reference

Europe PubMed Central

19 October 2017

Wan Yee Lau

2

1 reference

Europe PubMed Central

19 October 2017

Feng Shen

3

1 reference

Europe PubMed Central

19 October 2017

Ze-Ya Pan

4

1 reference

Europe PubMed Central

19 October 2017

Si-Yuan Fu

5

1 reference

Europe PubMed Central

19 October 2017

Yun Yang

6

1 reference

Europe PubMed Central

19 October 2017

Wei-Ping Zhou

7

1 reference

Europe PubMed Central

19 October 2017

Meng-Chao Wu

8

1 reference

Europe PubMed Central

19 October 2017

publication date

1 September 2014

1 reference

Europe PubMed Central

19 October 2017

World Journal of Surgery

1 reference

Europe PubMed Central

19 October 2017

38

1 reference

Europe PubMed Central

19 October 2017

9

1 reference

Europe PubMed Central

19 October 2017

2370-2376

1 reference

Europe PubMed Central

19 October 2017

https://scigraph.springernature.com/pub.10.1007/s00268-014-2546-7

0 references

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2:333-39.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

The immune response during hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

T cells and viral persistence: lessons from diverse infections

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Viral determinants and host immune responses in the pathogenesis of HBV infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Stealth and cunning: hepatitis B and hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2546-7

21 January 2018

Perioperative mortality for management of hepatic neoplasm: a simple risk score

1 reference

https://pubmed.ncbi.nlm.nih.gov/24696061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24696061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24696061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular virology and pathogenesis of hepatitis B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24696061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma: current surgical management

1 reference

https://pubmed.ncbi.nlm.nih.gov/24696061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade

1 reference

https://pubmed.ncbi.nlm.nih.gov/24696061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Causes of death in patients undergoing liver surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/24696061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bile leakage after hepatic resection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24696061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24696061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/24696061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00268-014-2546-7

1 reference

Europe PubMed Central

19 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42227308&oldid=1937093026"